B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1

Nature Immunology

Volumn 2, Issue 1, 2001, Pages 69-74

  Schubart, Karin ^a   Massa, Steffen ^a   Schubart, Daniel ^a,d   Corcoran, Lynn M ^b   Rolink, Antonius G ^c   Matthias, Patrick ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^d Axxima Pharmaceuticals AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OCTAMER TRANSCRIPTION FACTOR 2; POU2AF1 PROTEIN, MOUSE; POU2F2 PROTEIN, MOUSE; PRIMER DNA; RNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; GERMINAL CENTER; IMMUNOGLOBULIN GENE; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, IMMUNOGLOBULIN; GERMINAL CENTER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; OCTAMER TRANSCRIPTION FACTOR-2; RNA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0035229734     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/83190     Document Type: Article

References (44)

1. Henderson, A. & Calame, K. Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16, 163-200 (1998).
2. Ernst, P. & Smale, S.T. Combinatorial regulation of transcription II:The immunoglobulin μ heavy chain gene. Immunity 2, 427-438 (1995).
3. Arulampalam, V., Eckhardt, L. & Pettersson, S. The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol. Today 18, 549-554 (1997).
4. Mizushima-Sugano, J. & Roeder, R. G. Cell-type-specific transcription of an immunoglobulin κ light chain promoter gene in vitro. Proc. Natl Acad. Sci. USA 83, 8511-8515 (1986).
5. Mason, J. O., Williams, G. T. & Neuberger, M. S. Transcription cell-type specificity is controlled by an immunoglobulin VH promoter that includes a functional consensus sequence. Cell 41, 479-487 (1985).
6. Dreyfus, M., Doyen, N. & Rougeon, F. The conserved decanucaleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B cells when introduced into a heterologous promoter. EMBO J. 6, 1685-1690 (1987).
7. Wirth, T., Staudt, L. & Baltimore, D. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature 329, 174-177 (1987).
8. Bergman, Y., Rice, D., Grosschedl, R. & Baltimore, D. Two regulatory elements for immunoglobulin kappa light chain gene expression. Proc. Natl Acad. Sci. USA 81, 7041-7045 (1984).
9. Jenuwein, T. & Grosschedl, R. Complex pattern of immunoglobulin μ gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. Genes Dev. 5, 932-943 (1991).
10. Matthias, P. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what? Semin. Immunol. 10, 155-163 (1998).
11. Hermanson, G. G., Briskin, M., Sigman, D. & Wall, R. Immunoglobutin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene. Proc. Natl Acad. Sci. USA 86, 7341-7345 (1989).
12. Thevenin, C., Lucas, B. P., Kozlow, E. J. & Kehrl, J. H. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J. Biol. Chem. 268, 5949-5956 (1993).
13. Christensen, S. M., Martin, B. K., Tan, S. S. & Weis, J. H. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. J. Immunol. 148, 3610-3617 (1992).
14. Ryan, A. K. & Rosenfeld, M. G. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 11, 1207-1225 (1997).
15. Bertolino, E., Tiedt, R., Matthias, P. & Singh, H. Role of Octamer Transcription Factors and their Coactivators in the lymphoid system in Transcription Factors: Normal and Malignant Development of Blood Cells (eds. Ravid, K. & Licht, J.) (Wiley & Sons, New York, in the press, 2000).
16. Strubin, M., Newell, J. W. & Matthias, P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80, 497-506 (1995).
17. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner, W. & Hovens, C. M. A B-cell coactivator of octamer-binding transcription factors. Nature 373, 360-362 (1995).
18. Luo, Y. & Roeder, R. G. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15, 4115-4124 (1995).
19. Gstaiger, M., Georgiev, O., van Leeuwen, H., van der Vliet, P. & Schaffner, W. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15, 2781-2790 (1996).
20. Müller, M. M., Ruppert, S., Schaffner, W. & Matthias, P. A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature 336, 544-551 (1988).
21. Corcoran, L. et al. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7, 570-582 (1993).
22. Humbert, P. O. & Corcoran, L. M. oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. J. Immunol. 59, 5273-5284 (1997).
23. Corcoran, L. M. & Karvelas, M. Oct-2 is required early in T cell-independent B cell activation for GI progression and for proliferation. Immunity 1, 635-645 (1994).
24. Feldhaus, A. L., Klug, C.A., Arvin, K. L. & Singh, H. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J. 12, 2763-2772 (1993).
25. Schubart, D. B., Rolink, A., Kosco-Vilbois, M. H., Botteri, F. & Matthias, P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383, 538-542 (1996).
26. Kim, U. et al. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383, 542-547 (1996).
27. Nielsen, P. J., Georgiev, O., Lorenz, B. & Schaffner, W. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26, 3214-3218 (1996).
28. Qin, X.-F., Reichlin, A., Luo, Y., Roeder, R. G. & Nussenzweig, M. C. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 17, 5006-5075 (1998).
29. Schubart, D. B., Rolink, A., Schubart, K. & Matthias, P. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. J. Immunol. 164, 18-22 (2000).
30. Rolink, A., Grawunder, U., Winkler, T. H., Karasuyama, H. & Metchers, F. IL-2 receptor alpha chain (CD25,TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257-1264 (1994).
31. Rolink, A. G., Andersson, J. & Melchers, F. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 28, 3738-3748 (1998).
32. Kang, S. M. et al. Induction of the POU domain transcription factor Oct-2 duringT-cell activation by cognate antigen. Mol. Cell. Biol. 12, 3149-3154 (1992).
33. Sauter, P. & Matthias, P. The B cell-specific coactivator OBF-1 (OCA-B, Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction, Immunobiology 197, 293-302 (1997).
34. Zwilling, S., Dieckmann, A., Pfisterer, P., Angel, P. & Wirth, T. Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 inT cells. Science 277, 221-225 (1997).
35. Wolf, I. et al. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 273, 28831-28836 (1998).
36. Konig, H., Pfisterer, P., Corcoran, L. M. & Wirth, T. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev. 9, 1598-1607 (1995).
37. LeBowitz, J. H., Kobayashi, T., Staudt, L. M., Baltimore, D. & Sharp, P.A. Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy chain promoter in vitro. Genes Dev. 2, 1227-1237 (1988).
38. Shah, P. C., Bertolino, E. & Singh, H. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J. 16, 7105-7117 (1997).
39. Forster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037-1047 (1996).
40. Rolink, A. G. et al. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 10, 619-628 (1999).
41. + cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183, 187-194 (1996).
42. Ausubel, F. et al. Current Protocols in Molecular Biology (Greene Publishing and Wiley-Interscience, New York, 1990).
43. Coligan, J. E. Current Protocols in Immunology (Greene Publishing and Wiley-Interscience, New York, 1992).
44. Rolink, A. et al. B-cell development in mouse and man. Immunologist 3, 125-128 (1995).